Oct 2026
ctDNA clearance and outcomes for resectable lung cancer from NeoCOAST-2.
L. McGrath, Gozde Kar, L. Bonanno et al.
· Nature · 0 citations
We have 3 of 225 papers
We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.
Not the right person? Other researchers publish under this name.
Review
Open access
Jul 2026
Anti-TROP2 Antibody Drug Conjugates in EGFR-Mutant Non-Small Cell Lung Cancer: Biological Rationale and Clinical Challenges
From a mechanistic standpoint, TROP2 occupies a unique and dynamic role in EGFR-mutated NSCLC, providing strong biological rationale for clinical development of anti-TROP2 ADCs in this population.
L. Bonanno, Alberto Ronchi, Loc Carlo Bao et al.
· Pharmaceutics · 0 citations
Open access
Jul 2026
Comparing Real-Time PCR and Amplicon-Based NGS for Routine EGFR Liquid Biopsy Profiling
This study evaluated the amplicon-based NGS Plasma-SeqSensei™ Solid Cancer In Vitro Diagnostics (IVD) Kit (Sysmex) against the real-time PCR-based cobas® EGFR Mutation Test v2 (Roche), the current routine standard at the Veneto Institute of Oncology IOV-IRCCS, finding it to be a robust and highly sensitive assay.
Andrea Boscolo Bragadin, Valeria Tosello, S. Longo et al.
· Diagnostics · 0 citations